Trial Profile
A phase II trial to investigate the efficacy of cetuximab added to cisplatin and vinorelbine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms LUCAS
- Sponsors Merck KGaA
- 05 Nov 2010 New trial record.